Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Front Immunol ; 14: 1183465, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37292196

RESUMO

Introduction: The tumor microenvironment (TME) of glioblastoma (GB) is characterized by an increased infiltration of immunosuppressive cells that attenuate the antitumor immune response. The participation of neutrophils in tumor progression is still controversial and a dual role in the TME has been proposed. In this study, we show that neutrophils are reprogrammed by the tumor to ultimately promote GB progression. Methods: Using in vitro and in vivo assays, we demonstrate the existence of bidirectional GB and neutrophil communication, directly promoting an immunosuppressive TME. Results and discussion: Neutrophils have shown to play an important role in tumor malignancy especially in advanced 3D tumor model and Balb/c nude mice experiments, implying a time- and neutrophil concentration-dependent modulation. Studying the tumor energetic metabolism indicated a mitochondria mismatch shaping the TME secretome. The given data suggests a cytokine milieu in patients with GB that favors the recruitment of neutrophils, sustaining an anti-inflammatory profile which is associated with poor prognosis. Besides, glioma-neutrophil crosstalk has sustained a tumor prolonged activation via NETs formation, indicating the role of NFκB signaling in tumor progression. Moreover, clinical samples have indicated that neutrophil-lymphocyte ratio (NLR), IL-1ß, and IL-10 are associated with poor outcomes in patients with GB. Conclusion: These results are relevant for understanding how tumor progression occurs and how immune cells can help in this process.


Assuntos
Glioblastoma , Neutrófilos , Animais , Camundongos , Camundongos Nus , Transdução de Sinais , Imunidade , Microambiente Tumoral
2.
Purinergic Signal ; 17(3): 371-383, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-33913070

RESUMO

Nucleotide signaling is a key element of the neutrophil activation pathway. Neutrophil recruitment and migration to injured tissues is guided by purinergic receptor sensitization, mostly induced by extracellular adenosine triphosphate (ATP) and its hydrolysis product, adenosine (ADO), which is primarily produced by the CD39-CD73 axis located at the neutrophil cell surface. In inflammation unrelated to cancer, neutrophil activation via purinergic signaling aims to eliminate antigens and promote an immune response with minimal damage to healthy tissues; however, an antagonistic response may be expected in tumors. Indeed, alterations in purinergic signaling favor the accumulation of extracellular ATP and ADO in the microenvironment of solid tumors, which promote tumor progression by inducing cell proliferation, angiogenesis, and escape from immune surveillance. Since neutrophils and their N1/N2 polarization spectrum are being considered new components of cancer-related inflammation, the participation of purinergic signaling in pro-tumor activities of neutrophils should also be considered. However, there is a lack of studies investigating purinergic signaling in human neutrophil polarization and in tumor-associated neutrophils. In this review, we discussed the human neutrophil response elicited by nucleotides in inflammation and extrapolated its behavior in the context of cancer. Understanding these mechanisms in cancerous conditions may help to identify new biological targets and therapeutic strategies, particularly regarding tumors that are refractory to traditional chemo- and immunotherapy.


Assuntos
Neoplasias/metabolismo , Neutrófilos/metabolismo , Nucleotídeos/metabolismo , Receptores Purinérgicos/metabolismo , Transdução de Sinais/fisiologia , Animais , Humanos , Neoplasias/patologia , Neutrófilos/patologia
3.
Rev. bras. farmacogn ; 22(4): 825-837, jul.-ago. 2012. tab
Artigo em Inglês | LILACS | ID: lil-640359

RESUMO

Currently, algae and algae products are extensively applied in the pharmaceutical, cosmetic and food industries. Algae are the main organisms that take up and store heavy metals. Therefore, the use of compounds derived from algae by the pharmaceutical industry should be closely monitored for possible contamination. The pollution generated by heavy metals released by industrial and domestic sources causes serious changes in the aquatic ecosystem, resulting in a loss of biological diversity and a magnification and bioaccumulation of toxic agents in the food chain. Since algae are at the bottom of the aquatic food chain, they are the most important vector for transfer of pollution to upper levels of the trophic chain in aquatic environments. Moreover, microalgae are also used for the bioremediation of wastewater, a process that does not produce secondary pollution, that enables efficient recycling of nutrients and that generates biomass useful for the production of bioactive compounds and biofuel.

4.
Rev. bras. farmacogn ; 21(2): 361-364, mar.-abr. 2011. ilus, graf, tab
Artigo em Inglês | LILACS | ID: lil-590189

RESUMO

In this work we described the cultivation of Chlorella vulgaris in a photobioreactor to algal biomass production. The dried biomass was used as feedstock for biodiesel production, it presented 26 percent lipids and via sonocatalysis stage of the methodology resulted in 60 percent of fatty acid methyl esters (FAME). The FAME content was confirmed by Gas Chromatography (GC).

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...